Real-World IVF drug use under the microscope
NCT ID NCT05499052
Summary
This study observed how a fertility drug called REKOVELLE® was used in everyday medical practice for women undergoing their first IVF treatment. Researchers tracked 201 women to see how doctors decided on doses, monitored safety, and what pregnancy outcomes resulted. The goal was to understand real-world patterns, not to test a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONTROLLED OVARIAN STIMULATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ferring Investigational Site
Copenhagen, Denmark
-
Ferring Investigational Site
Horsens, Denmark
-
Ferring Investigational Site
Køge, Denmark
-
Ferring Investigational Site
Odense, Denmark
-
Ferring Investigational Site
Søborg, Denmark
-
Ferring Investigational Site
Skien, Norway
-
Ferring Investigational Site
Malmo, Sweden
-
Ferring Investigational Site
Baden, Switzerland
-
Ferring Investigational Site
Basel, Switzerland
Conditions
Explore the condition pages connected to this study.